Aspen Group Inc. (ASPU)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Aspen Aerogels: Tariffs, Tesla And The Silver Lining
Aspen Aerogels' growth is tied to the EV market, which faces uncertainty due to potential elimination of the EV tax credit. Despite fears, Aspen Aerogels may benefit from Tesla's declining market share, as smaller EV players gain traction, particularly in Europe and China. US EV sales are expected to plateau until 2027, potentially limiting Aspen's revenue growth. But international markets offer expansion opportunities.
Aspen Insurance Preferreds Update: All Still Rated Hold
Apollo Global Management plans to spin off Aspen Insurance Holdings Limited in 2025, targeting a $4 billion valuation, after postponing the IPO due to unfavorable market conditions. Aspen Insurance redeemed its 5.95% "C" preferred stock using funds from a recently issued 7% preferred, signaling positive financial health for existing preferreds. Aspen's Q3 results show improved financials, with $3 billion available to cover preferred stockholders, indicating a strong coverage ratio and market confidence.
Aspen Pharmacare Holdings Limited (APNHF) Q2 2025 Earnings Call Transcript
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q2 2025 Results Conference Call March 4, 2025 1:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Executive Officer Sean Capazorio - Group Chief Financial Officer Sibongakonke Nkosi Good morning. A very warm welcome to everyone joining us in person, online for Aspen's 2025 Interim Results Presentation.
Activist Elliott takes a stake in Aspen Technology and pushes back on an offer from Emerson
Elliott Investment Management has a $1.5 billion stake in Aspen Technology, and the activist disagrees with a tender offer from Emerson Electric.
Trade Desk Posts Downbeat Revenue, Joins Aspen Aerogels, Fastly And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.1% on Thursday.
Aspen's Q2 Earnings & Revenues Surpass Estimates, Increase Y/Y
AZPN reports better-than-expected fiscal second-quarter results. Also, both the top and bottom lines increase year over year.
Aspen to Be Acquired by Emerson in an All-Cash $7.2 Billion Deal
Emerson is set to acquire all remaining outstanding shares of AZPN's common stock, valuing the minority stake at $7.2 billion.
Aspen Technology Stock Hits All-Time High as Emerson Buys Remaining Shares
Software maker Aspen Technology (AZPN) shares hit an all-time high Monday when technology and software provider Emerson Electric (EMR) said it would buy the remaining shares of AspenTech it doesn't already own for about $7.2 billion.
Aspen Aerogels: Higher Risk But Can't Deny It's Cheap
Aspen Aerogels is emerging as a key player in aerogel insulation, with major clients like ExxonMobil and a focus on electric vehicles and energy storage. The company reported impressive numbers: 93% YoY revenue growth, $25.4 million in adjusted EBITDA, and a $1.7 billion revenue pipeline by 2026. Aspen's PyroThin product, crucial for electric vehicles, contributes 77% of their revenue, highlighting their strategic shift towards the EV market.
Aspen Aerogels: There Are Reasons To Be Careful But It's So Cheap
The company has recently taken on significant debt to finance its Statesboro plant. Stock were issued to improve the balance. The market didn't like but could make sense if it's compensated with growth thanks to the new Statesboro Plant. Q3 2024 earnings showed 92.93% YoY revenue growth and improved margins, but flat quarter-over-quarter sales led to a 28% stock decline.
Aspen's DGM Software Witnesses Continued Adoption: Stock to Gain?
By harnessing the power of AZPN's flagship DGM solution, ISA achieves 99.99% power reliability across roughly 16,395 miles of circuits in Latin America.
Aspen Aerogels: Thermal Barriers Could Sustain Further Growth Despite A Chilly Market
I find Aspen's 93% YoY revenue growth in Q3 2024 quite impressive, driven entirely by organic demand for PyroThin thermal barriers, with revenue guidance raised significantly this year. Gross margins climbed to 42% in the past quarter, while adj. EBITDA is projected to reach $90M in FY2024. Management's debt refinancing decision reduces dilution risks in the long term, a move I highly favor, despite the recent public offering.
